"The US Food and Drug Administration (FDA) today approved asfotase alfa (Strensiq, Alexion Pharmaceuticals) as the first-ever therapy for patients who develop hypophosphatasia, a rare metabolic bone disorder, in childhood.
Morrhuate Sodium Injection, USP, is a mixture of the sodium salts of the saturated and unsaturated fatty acids of Cod Liver Oil. Morrhuate Sodium (morrhuate sodium injection) Injection, USP is prepared by the saponification of selected Cod Liver Oils. It is overlaid with filtered Nitrogen to prevent discoloration that occurs on exposure to oxygen. Morrhuate Sodium (morrhuate sodium injection) occurs as a pale-yellowish, granular powder with a slight fishy odor and is soluble in water and in alcohol.
Each mL contains: (morrhuate sodium (morrhuate sodium injection) injection) Morrhuate Sodium (morrhuate sodium injection) 50 mg, Benzyl Alcohol 2% w/v (as Local Anesthetic), Water for Injection q.s. pH adjusted with Sodium Hydroxide and/or Hydrochloric Acid.
The pH of the injection is adjusted to approximately 9.5.
NOTE: PRODUCT MAY SHOW A SEPARATION OF A SOLID MATTER ON STANDING. DO NOT USE IF SUCH SOLID DOES NOT DISSOLVE COMPLETELY UPON WARMING.
Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.
Additional Morrhuate Sodium Information
Report Problems to the Food and Drug Administration
Find out what women really need.